(Q34240797)

31 July 2017

1 reference

title

Pharmacology and clinical experience with tiagabine (English)

1 reference

31 July 2017

1 reference

Schachter SC

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

179-187

1 reference

31 July 2017

cites work

Pregnancy and epilepsy.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

A survey of epileptic disorders in southwest France: seizures in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Blockade of GABA uptake with tiagabine inhibits audiogenic seizures and reduces neuronal firing in the inferior colliculus of the genetically epilepsy-prone rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

GABA uptake inhibitors: relevance to antiepileptic drug research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Effects of tiagabine monotherapy on abilities, adjustment, and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Clinical and EEG findings in complex partial status epilepticus with tiagabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

Tiagabine-induced absence status in idiopathic generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.179

21 January 2018

Identifiers

DOI

10.1517/14656566.2.1.179

1 reference

31 July 2017

1 reference